Spectrum Pharmaceuticals, Inc.SPPINASDAQ
Loading
Year-over-year research & development expense growth
Latest
-37.43%
↓ 446% vs avg
Percentile
P10
Near historical low
Streak
3 qtr
Consecutive declineDecelerating
Average
10.83%
Historical baseline
| Period | Value |
|---|---|
| Q1 2023 | -37.43% |
| Q4 2022 | -34.99% |
| Q3 2022 | -16.69% |
| Q2 2022 | 281.76% |
| Q1 2022 | -76.66% |
| Q4 2021 | -13.85% |
| Q3 2021 | -28.38% |
| Q2 2021 | 50.30% |
| Q1 2021 | -58.95% |
| Q4 2020 | 92.96% |
| Q3 2020 | 12.45% |
| Q2 2020 | 35.97% |
| Q1 2020 | -31.33% |
| Q4 2019 | 35.67% |
| Q3 2019 | 1.09% |
| Q2 2019 | -22.41% |
| Q1 2019 | -36.59% |
| Q4 2018 | 63.88% |
| Q3 2018 | -1.99% |
| Q2 2018 | 20.08% |
| Q1 2018 | -19.15% |
| Q4 2017 | 59.49% |
| Q3 2017 | -8.07% |
| Q2 2017 | 2.73% |
| Q1 2017 | -7.57% |
| Q4 2016 | 19.60% |
| Q3 2016 | -6.92% |
| Q2 2016 | -7.64% |
| Q1 2016 | 0.19% |
| Q4 2015 | 55.51% |
| Q3 2015 | 3.83% |
| Q2 2015 | -39.70% |
| Q1 2015 | 10.00% |
| Q4 2014 | -0.07% |
| Q3 2014 | 27.22% |
| Q2 2014 | -61.57% |
| Q1 2014 | 174.14% |
| Q4 2013 | -20.69% |
| Q3 2013 | 29.20% |
| Q2 2013 | -12.35% |